Using genetic testing to improve treatment for opioid use disorder
Pharmacogenomic Testing to Optimize Opioid Use Disorder Treatment: Acceptability and Feasibility Trial
This study is looking at how using genetic testing can help improve treatment for people with opioid use disorder by finding out what patients and healthcare providers think about it, and it will also create helpful resources to make the process easier for everyone involved.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington State University NIH-funded |
| Lab location | 1 site (Pullman, United States) |
| Project ID | NIH-11054422 on NIH RePORTER |
What this research studies
This research investigates how pharmacogenomic testing can enhance the treatment of opioid use disorder by assessing its acceptability and feasibility among patients and healthcare providers. The study will engage patients, providers, and clinic staff through surveys to identify barriers and facilitators to implementing genetic testing in treatment protocols. Additionally, it aims to develop educational resources for both providers and patients, and evaluate the effectiveness of genetic testing in guiding methadone dosing through a randomized controlled trial.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are seeking treatment options.
Not a fit: Patients who are not diagnosed with opioid use disorder or those who are not seeking treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for individuals struggling with opioid use disorder.
How similar studies have performed: Previous research has shown promising results in using pharmacogenomic approaches for various treatments, indicating potential success for this novel application in opioid use disorder.
Where this research is happening
Pullman, United States
- Washington State University — Pullman, United States (Active)
Researchers
- Principal investigator: Smith, Crystal Lederhos — Washington State University
- Study coordinator: Smith, Crystal Lederhos
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.